Company Search:
Advanced Search
Sponsored Links
Biotest AG Company Snapshot
Biotest AG operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Biotest AG with three other pharmaceutical manufacturers in Europe: FAES Farma SA of Spain (2017 sales of 274.58 million Euro [US$310.61 million] of which 84% was Speciality Pharmaceuticals), Dechra Pharmaceuticals PLC of the United Kingdom (£359.28 million [US$464.18 million] of which 63% was European Pharmaceuticals), and Vetoquinol Sa which is based in France (352.17 million Euro [US$398.39 million] of which 56% was Europe).

Sales Analysis. During the year ended December of 2017, sales at Biotest AG were 378.10 million Euro (US$427.71 million). This is a sharp decrease of 31.6% versus 2016, when the company's sales were 553.10 million Euro. Contributing to the drop in overall sales was the 70.8% decline in Plasma and Services, from 199.30 million Euro to 58.20 million Euro. There were also decreases in sales in Therapy (down 9.5% to 313.70 million Euro) and Other (down 11.4% to 6.20 million Euro) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Biotest AG
  Stock Performance Chart for Biotest AG
  Stock Data: Recent Stock Performance:
  Current Price (2/15/2019): 22.25
(Figures in Euro)
1 Week 0.7%   13 Weeks -1.5%  
4 Weeks 6.0%   52 Weeks -18.3%  
Biotest AG Key Data:
  Ticker: BIO3 Country: Germany
  Exchanges: FRA Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 378,100,000
(Year Ending Jan 2018).
Employees: 2,474
  Currency: Euro Market Cap: 880,464,807
  Fiscal Yr Ends: December Shares Outstanding: 39,571,452
  Share Type: Vorzugsaktie Closely Held Shares: 17,783,776
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.